Crystallographic Evidence for Dimerization of Unliganded Tumor Necrosis Factor Receptor (*)

Activation of the cell surface receptors for tumor necrosis factor (TNF) is effected by the aggregation of cytoplasmic domains that occurs when the extracellular domains of two or three receptors bind to trimeric TNFα or TNFβ. The structure of the type I TNF receptor extracellular domain (sTNF-R1), crystallized in the absence of TNF, has now been determined at 2.25-Å resolution. The receptor itself is an elongated molecule comprising four disulfide-rich domains in a nearly linear array. Contrary to expectations, the unliganded domains are found to associate into dimers of two distinct types, in which monomers are related by local two-fold axes of symmetry. In one case, the receptors are antiparallel to each other and associate through an interface that overlaps the TNF binding site. If intact receptors were capable of such an association, their cytoplasmic domains would be separated by over 100 Å. This interaction could inhibit signaling in the absence of TNF. Parallel dimers are also observed in which the dimer interface is well separated from the TNF binding site. Associations among TNF-bound parallel dimers could cause receptor clustering. Both dimers bury substantial areas of protein surface and are formed by polar and non-polar interactions.

[1]  L. Tartaglia,et al.  Tumor necrosis factor receptor signaling. A dominant negative mutation suppresses the activation of the 55-kDa tumor necrosis factor receptor. , 1992, Journal of Biological Chemistry.

[2]  C Chothia,et al.  Surface, subunit interfaces and interior of oligomeric proteins. , 1988, Journal of molecular biology.

[3]  G J Williams,et al.  The Protein Data Bank: a computer-based archival file for macromolecular structures. , 1977, Journal of molecular biology.

[4]  J. Camonis,et al.  Self-association of the Death Domains of the p55 Tumor Necrosis Factor (TNF) Receptor and Fas/APO1 Prompts Signaling for TNF and Fas/APO1 Effects (*) , 1995, The Journal of Biological Chemistry.

[5]  D. Bacon,et al.  A fast algorithm for rendering space-filling molecule pictures , 1988 .

[6]  N. Xuong,et al.  Characteristics of a flat multiwire area detector for protein crystallography , 1981 .

[7]  D. Wallach,et al.  Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. , 1990, The Journal of biological chemistry.

[8]  F. Balkwill Cytokines in health and disease. , 1993, Immunology today.

[9]  P. Kraulis A program to produce both detailed and schematic plots of protein structures , 1991 .

[10]  J. Bazan Emerging families of cytokines and receptors , 1993, Current Biology.

[11]  D. Banner,et al.  Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: Implications for TNF receptor activation , 1993, Cell.

[12]  H. Holtmann,et al.  Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. , 1990, The Journal of biological chemistry.

[13]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[14]  Z Bajzer,et al.  Binding, internalization, and intracellular processing of proteins interacting with recycling receptors. A kinetic analysis. , 1989, The Journal of biological chemistry.

[15]  M. Lawrence,et al.  Shape complementarity at protein/protein interfaces. , 1993, Journal of molecular biology.

[16]  Peter Main,et al.  Histogram matching as a new density modification technique for phase refinement and extension of protein molecules , 1990 .

[17]  H. Schoenfeld,et al.  Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[18]  B. Lee,et al.  The interpretation of protein structures: estimation of static accessibility. , 1971, Journal of molecular biology.

[19]  S. Sprang,et al.  Two crystal forms of the extracellular domain of type I tumor necrosis factor receptor. , 1994, Journal of molecular biology.

[20]  B. Beutler,et al.  Tumor Necrosis Factor: The molecules and Their Emerging Role in Medicine , 1992 .

[21]  G. Wong,et al.  Molecular cloning and expression of a receptor for human tumor necrosis factor , 1990, Cell.

[22]  D. Donner,et al.  Aggregation of the intracellular domain of the type 1 tumor necrosis factor receptor defined by the two-hybrid system. , 1994, Journal of Biological Chemistry.

[23]  P. Main,et al.  The use of Sayre's equation with solvent flattening and histogram matching for phase extension and refinement of protein structures , 1990 .

[24]  H. Tabuchi,et al.  Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor , 1990, Cell.